NovaBridge Biosciences (NBP) Income from Discontinued Operations (2023 - 2024)
Powered by 
Analysis
NovaBridge Biosciences (NBP) Income from Discontinued Operations (2023 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.37 Bn | 130.52 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.18 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.33 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.92 Bn | 52.78 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.38 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | NovaBridge Biosciences | 199.33 Mn | 199.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 27.47 Mn |
| Sep 30, 2024 | -34.36 Mn |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | -6.90 Mn |
| Dec 31, 2023 | -125.51 Mn |
| Sep 30, 2023 | -300.00 |
| Jun 30, 2023 | -410.00 |